SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRK is drawing attention after a sharp rally and elevated trading activity, with traders pointing to Starknets privacy features, Bitcoin DeFi plans, and post-quantum security as potential catalysts. The reaction is divided between optimism about the projects technology and concerns that the move could be a speculative pump amid token-unlock selling pressure.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAO is drawing attention amid a price rebound, with traders discussing entry points and renewed interest in Bittensors decentralized-AI theme. Some link the move to a broader AI-token rally and speculate that China could ease crypto restrictions, but that claim is unconfirmed; others remain cautious about volatility.

TRON is a decentralized blockchain-based operating system designed to accelerate the decentralization of the internet and its underlying infrastructure. It serves as a global settlement layer for stablecoins and everyday digital purchases, providing a high-throughput environment to support large-scale decentralized applications. The network is governed by a decentralized autonomous organization (DAO), which allows the community to manage the protocol without a central authority. Its primary value proposition includes a unique resource model that utilizes bandwidth and energy to allow for high transaction volumes without traditional fee spikes.  The platform functions as a smart contract platform that enables the creation of decentralized applications and is compatible with the Ethereum Virtual Machine, allowing developers to easily migrate applications. TRON operates using a Delegated Proof of Stake consensus mechanism where token holders vote for 27 Super Representatives to verify transactions and maintain the ledger. This structure is built for scalability and fast finality, aiming to handle more transactions per second than many established legacy blockchains. Users can interact with the ecosystem for various purposes, including decentralized finance (DeFi) through platforms like JustLend DAO and decentralized storage via the BitTorrent File System.  Value moves through the system via its native utility token, TRX, which facilitates transactions and grants users access to network resources. Holders can lock their TRX in a staking mechanism to gain TRON Power, which is used to vote on network rules and elect Super Representatives, earning rewards for securing the network. Established by the TRON Foundation and led by founder Justin Sun, the project has transitioned into a community-led DAO. The ecosystem is supported by strategic partnerships with major global entities, including Samsung, which integrated TRON into its blockchain keystore, as well as BitTorrent, Opera, and Swisscom Blockchain.

Tron

TRX discussion centers on range-bound consolidation, with traders tracking support, resistance, and liquidity levels. Some holders view its steady action as strength, while others are frustrated by the lack of a stronger move.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

RH is drawing attention after a mixed Q2 earnings report and updated outlook; traders are debating whether the strong adjusted earnings result reflects improving business momentum or was materially helped by tariff refunds, with concerns about underlying demand and debt. Bears expect further weakness, while some bulls see the selloff as a buying opportunity and point to potential short-squeeze interest.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is gaining alongside vaccine stocks after reports of an NIH-backed push to accelerate personalized cancer vaccines, though traders note the company and Genentech halted a colorectal cancer vaccine trial after weak efficacy results. The community is also comparing BNTXs move with Modernas stronger rally and debating how much BioNTechs oncology pipeline stands to benefit.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

Golds pullback and concerns that elevated yields and Fed rate-hike risks will weigh on bullion are driving debate around GDX. Traders are split between expecting more downside in the correction and buying for a rebound, with longer-term bulls pointing to debt concerns and central-bank gold demand.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNB is drawing attention for choppy consolidation after a rebound, with traders sharing technical setups and debating whether it can break resistance or retreat toward support. Bullish calls tied to broader crypto optimism contrast with concerns that BNB has been weak and the move may fade.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARKKs recent strength has sparked talk of a possible technical breakout and recovery, while traders remain divided over Cathie Woods strategy. Many criticize the funds historical underperformance and trade timing, while bullish voices point to improving charts and renewed growth-stock momentum.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Discussion centers on claims that Solana has chosen SQDs blockchain data-indexing network, alongside speculation about further Google-related developments and a possible buyback. Bullish holders see enterprise adoption as validation of SQDs infrastructure, while skeptics call the optimism hype and question whether network use will translate into token value.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillows steep selloff is being discussed in connection with its latest earnings and weaker residential outlook: traders note revenue growth but are concerned that softer housing activity and high mortgage rates are weighing on guidance. Some bulls view the decline as an overreaction to a still-growing business, while bears point to persistent housing-market and competitive pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alembic Pharma Gets USFDA Nod for Paroxetine ER Tablets

… this latest approval, Alembic Pharmaceuticals has further expanded its … approvals. Headquartered in Vadodara, Alembic Pharmaceuticals is a vertically integrated research … and development-driven pharmaceutical company with a legacy dating …

India's Alembic Pharmaceuticals expands into Thailand

… opportunities India-based Alembic Pharmaceuticals has announced the incorporation of … for the listed entity. Alembic Pharmaceuticals holds a substantial controlling stake … International Generics, and Active Pharmaceutical Ingredients with vertical integration …

Alembic Pharma Gets 2 USFDA Observations for Karakhadi Injectable Facility

Vadodara: Alembic Pharmaceuticals Limited has informed that the … related to data integrity. Alembic Pharmaceuticals further stated that it will …

Alembic Pharma Gets USFDA Final Approval for Parkinson's Drug Stalevo Generic

… , and regulatory compliance. Alembic Pharmaceuticals Limited, founded in 1907, … integrated research and development-driven pharmaceutical company headquartered in India. … manufactures and markets generic pharmaceutical products globally and operates …

Alembic Pharmaceuticals Limited - 02/06/2021

Alembic Pharmaceuticals Limited - 02/06/2021. Country: India. Record Type: 483

Alembic Pharmaceuticals Limited - 11/10/2021

Alembic Pharmaceuticals Limited - 11/10/2021. Country: India. Record Type: 483

Business News | India's Healthcare, Pharma & Biotech HR Leaders Converge at Team Marksmen Network's Most Preferred Workplaces 2025-26

… Patwari, CHRO, Alembic Pharmaceuticals Limited; Dr. … Abbott India * Alembic Pharmaceuticals Ltd. * Apollo Hospitals … Enterprise Limited * CADILA PHARMACEUTICALS LIMITED * Dr. Reddy… Dhirubhai Ambani Hospital * Matrix Pharmacorp * Medtronic * P. D …

Alembic Pharma receives USFDA final approval for Travoprost Ophthalmic solution

Mumbai: Alembic Pharmaceuticals Limited announced that it has … 2025. With this approval, Alembic Pharmaceuticals now has a cumulative total …

Alembic Pharma bags USFDA nod for blood cancer drug Dasatinib

… mg, and 140 mg, of Bristol-Myers Squibb Company (BMS). Dasatinib tablets are … Suspension Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated … research and development pharmaceutical company. The company is a …

India Mucormycosis Treatment (Black Fungus Drugs) Market to Get an Explosive Growth | Natco Pharmaceuticals, Alembic Pharmaceuticals, Gufic Biosciences

The India Mucormycosis Treatment (Black Fungus Drugs) market is estimated to be valued at USD 9.1 Mn in 2025 and is expected to reach USD 11.7 Mn by 2032, growing at a compound annual growth rate CAGR of 3.5% from

Alembic Pharmaceuticals Ltd. is a research and development pharmaceutical company, which engages in the research, development, manufacture, and market of generic and branded pharmaceutical products. The firm's businesses are Active Pharmaceutical Ingredients and Formulations. It focuses on the following therapeutic areas: Dermatology, Cardiology, Anti-Diabetic, Gastrology, Ophthalmology, Nephrology and Urology, Anti-Infective, Oncology, and cold and cough. The company was founded by Tribhuvandas Kalyandas Gajjar in 1907 and is headquartered in Vadodara, India.

Current Price	800.90
Prev Close	800.00
Open	801.00
Dividend Yield	1.81%
50-Day Moving Average	825.63
Beta	0.05
Avg. Volume	225,826.24
PE Ratio	22.70

52-Week High	998.00
52-Week Low	635.80
Market Capitalization	157.46B
EPS (Annual)	34.33
Price to Book	2.74
Revenue Per Employee	3.59M

Feed

News

Sentiment

Fundamentals

Info

APLLTD.NSE Fundamentals